Table 2. Clinical and demographics summary.
| Table 2A Overall Summary | |||||||
|---|---|---|---|---|---|---|---|
| Site | N | Age (sd) |
Medications (med. free, SSRI/SNRI, TCA, AP*) |
Average number of ECT |
Baseline MADRS | Δ MADRS (%) | |
| All | 151 | 57.5 (17.1) |
69,65,10,62 | 10.6 | 33.9 | 61.3 | |
| Female | 92 | 56.4 (18.4) | 42,36,8,42 | 10.4 | 34.4 | 63.4 | |
| Male | 59 | 59.3 (14.7) |
27,29,2,20 | 10.9 | 33.3 | 58.1 | |
| Table 2B Site Summary | |||||||
| Site | N | Age (mean) | Age (sd) | Baseline MADRS | Δ MADRS (%) | ||
| 1 | 30 | 39.87 | 12.68 | 40.73 | 45.12 | ||
| 2 | 33 | 64.48 | 8.93 | 31.36 | 69.48 | ||
| 3 | 16 | 73.62 | 12.45 | 29.56 | 77.24 | ||
| 4 | 23 | 46.87 | 9.19 | 29.96 | 43.18 | ||
| 5 | 2 | 62.50 | 0.71 | 36.75 | 32.03 | ||
| 6 | 18 | 48.50 | 16.77 | 33.83 | 57.12 | ||
| 7 | 29 | 72.66 | 7.57 | 35.07 | 79.13 | ||
*med. free: medication free, SSRI: selective serotonin reuptake inhibitor, SNRI: serotonin and norepinephrine reuptake inhibitors, TCA: tricyclic antidepressants, AP: antipsychotic medications, there were not patients on MAO inhibitors.